Cognitive Dysfunction in Fibromyalgia: Prevalence and Independent Predictors—A Case–Control Study Using the Montreal Cognitive Assessment Scale
Open Access
- 1 January 2026
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 16 (1) , 68
Abstract
Background: Cognitive dysfunction is a frequent but under-recognized feature of fibromyalgia (FM). Its prevalence varies widely across studies, and independent clinical predictors remain uncertain. This study aimed to determine the prevalence of cognitive dysfunction in FM patients compared with healthy controls and identify independent associated factors. Methods: We conducted a case–control study including 47 adult female patients with FM (2016 ACR criteria) and 19 age- and sex-matched healthy controls. Sociodemographic and clinical data were collected. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA), with cognitive dysfunction defined as MoCA < 26. Pain (VAS), fatigue (VAS and FACIT-F), anxiety and depression (HADS), sleep quality (PSQI), and disease impact (FIQ-P) were assessed. Univariate analysis was followed by binary logistic regression to identify independent predictors of cognitive dysfunction and multiple linear regression to explore associations with MoCA score. Results: Cognitive dysfunction was present in 72.3% of FM patients versus 5.3% of controls (p < 0.001). FM patients had significantly worse pain scores, fatigue levels, psychological distress, sleep quality, and quality of life (all p < 0.001). In FM patients, MoCA scores correlated inversely with pain (r = −0.34), anxiety (r = −0.34), depression (r = −0.48), disease impact (r = −0.43), and sleep disturbance (r = −0.48), and positively with FACIT-F (r = 0.37) and EQ-5D-5L (ρ = 0.60). In multivariate analysis, higher FIQ-P scores were independently associated with cognitive dysfunction [adjusted OR1.18; 95% CI (1.06–1.30); p < 0.01]. Pain severity [adjusted B = −0.40; 95%CI (−0.64–0.15; p < 0.01)] and depression [adjusted B = −2.60; 95% CI (−4.12–1.04; p = 0.001)] were independently associated with lower MoCA scores. Conclusions: Cognitive dysfunction is highly prevalent in FM and is independently associated with pain severity, depressive symptoms, and disease impact.Keywords
This publication has 37 references indexed in Scilit:
- Executive function in fibromyalgia: Comparing subjective and objective measuresComprehensive Psychiatry, 2016
- Fibrofog and fibromyalgia: a narrative review and implications for clinical practiceRheumatology International, 2015
- Worldwide Epidemiology of FibromyalgiaCurrent Pain and Headache Reports, 2013
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Elevated insular glutamate in fibromyalgia is associated with experimental painArthritis & Rheumatism, 2009
- Disruption of cognitive function in Fibromyalgia Syndrome ☆Pain, 2008
- Fatigue in cancer patients compared with fatigue in the general United States populationCancer, 2002
- Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndromeArthritis & Rheumatism, 1994
- Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritisArthritis & Rheumatism, 1992
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990